These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4079941)

  • 1. Unusual complement-mediated hemolytic kinetics at low ionic strength.
    Chang NS; Boackle RJ
    Mol Immunol; 1985 Oct; 22(10):1217-24. PubMed ID: 4079941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions.
    Chang NS; Boackle RJ
    Mol Immunol; 1986 Aug; 23(8):887-93. PubMed ID: 3796630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ; Frank MM
    J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM; Bryan CS; Hawiger J; Colley DG
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of optimal reaction conditions for an assay of the human alternative complement pathway.
    Joiner KA; Hawiger A; Gelfand JA
    Am J Clin Pathol; 1983 Jan; 79(1):65-72. PubMed ID: 6849295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V; Beuscher HU
    Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain.
    Wright JF; Shulman MJ; Isenman DE; Painter RH
    J Biol Chem; 1988 Aug; 263(23):11221-6. PubMed ID: 3136155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of complement functional efficiency by histidine-rich glycoprotein.
    Chang NS; Leu RW; Rummage JA; Anderson JK; Mole JE
    Blood; 1992 Jun; 79(11):2973-80. PubMed ID: 1375119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor.
    Tseng Y; Poon PH; Zavodszky P; Schumaker VN
    J Immunol; 1991 Sep; 147(6):1884-90. PubMed ID: 1890306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel assay for serum complement activity: C42 generation assay.
    Kobayashi E; Kitano E; Kitamura H
    Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the activation of C1 in serum.
    Faulmann EL; Boyle MD
    Mol Immunol; 1987 Jun; 24(6):655-60. PubMed ID: 3657802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent.
    Zapf S; Loos M
    Immunobiology; 1985 Sep; 170(3):123-32. PubMed ID: 3932188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.